In recently postmenopausal women, HRT reduced a composite of death, MI, or heart failure at 10 years

After 10 years of randomised treatment, women receiving hormone replacement therapy early after menopause had a significantly reduced risk of mortality, heart failure, or myocardial infarction, without any apparent increase in risk of cancer, venous thromboembolism, or stroke

ACP Journal Club. 2013 Feb 19;158:JC2-2.
Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 2012;345:e6409. [PubMed ID: 23048011].Web

Recent Blogs

09 Mar 25

What’s Next for Medical Weight Loss in Woodstock, GA

xxxxxxxx xxxxxxxx xxxxxxx Medical weight loss in Woodstock, GA is evolving, especially as new FDA regulations may soon halt the production of compounded semaglutide and tirzepatide. As a…

08 Feb 25

The Truth About GLP-1 Medications: Benefits, Side Effects & More

GLP-1 Medications like Semaglutide and Tirzepatide for weight loss and diabetes Introduction: GLP-1 medications, such as semaglutide and tirzepatide, have garnered significant attention for their roles in managing…